…nies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role of lead investor in a large number o...
Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction
IMAGES-007-HOUSE_OVERSIGHT_024045.txt
p.1
View source release ↗